Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: Implications in chemical atherogenesis

Annual Review of Pharmacology and Toxicology

Volumn 39, Issue , 1999, Pages 243-265

  Ramos, Kenneth S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Cell signaling; Extracellular matrix; Gene regulation; Oxidative injury

Indexed keywords

BENZO[A]PYRENE; OSTEOPONTIN;

ATHEROGENESIS; ATHEROSCLEROSIS; GENE EXPRESSION REGULATION; GENE TARGETING; ONCOGENE H RAS; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIOSCLEROSIS; BASE SEQUENCE; DNA ADDUCTS; ENVIRONMENTAL POLLUTANTS; GENES, RAS; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; OSTEOPONTIN; OXIDANTS; OXIDATION-REDUCTION; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION;

EID: 0032947559     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.39.1.243     Document Type: Review

References (17)

1. Salonen JT, Nyyssonen K, Salonen R, Porkkala-Sarataho E, Tuomainen TP, et al. 1997. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 95:840-45
2. Locher R, Suter PM, Weisser B, Vetter W. 1997. Low-density lipoprotein-induced formation of nitric oxide by cultured vascular smooth muscle cells of the rat. Eur. J. Clin. Invest. 27:603-10
3. Kontos HA, Wei EP, Dietrìch WD, Navari RM, Povlishock JT, et al. 1981. Mechanism of cerebral arteriolar abnormalities after acute hypertension. Am. J. Physiol. 240:H511-27
4. Wilson SK. 1990. Role of oxygen-derived free radicals in acute angiotensin. II. Induced hypertensive vascular disease in the rat. Circ. Res. 66:722
5. Zhao W, Parrish AR, Ramos KS. 1998. Constitutive and inducible expression of cytochrome P450IA1 and IB1 in human vascular endothelial and smooth muscle cells. In Vitro Cell. Dev. Biol. 34:671-73
6. Heinecke JW. 1997. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr. Opin. Lipidol. 8:268-74
7. Hoeschen RJ. 1997. Oxidative stress and cardiovascular disease. Can. J. Cardiol. 13:1021-25
8. Klatt P, Esterbauer H. 1998. Oxidative hypothesis of atherogenesis. J. Cardiovasc. Risk 3:346-51
9. Deleted in proof
10. Deleted in proof
11. Bond JA, Kocan RM, Benditt EP, Juchau MR. 1979. Metabolism of benzo[a]pyrene and 7,12-dimethylbenz-[a]anthracene in cultured human fetal aortic smooth muscle cells. Life Sci. 25:425-30
12. Bond JA, Hsueh-Ying LY, Majesky MW, Benditt EP, Juchau MR. 1980. Metabolism of benzo(a)pyrene and 7, 12-dimethylbenz[a] anthracene in chicken aortas: monooxygenation, bioactivation to mutagens, and covalent binding to DNA in vitro. Toxicol. Appl. Pharmacol. 52:323-35
13. Juchau MR, Bond JA, Benditt EP. 1976. Aryl H-monooxygenase and cytochrome P-450 in the aorta: possible role in atherosclerosis. Proc. Natl. Acad. Sci. USA 73:3723-25
14. Albert RE, Vanderlaan M, Burns FJ, Nishiizumi M. 1977. Effects of carcinogens on chicken atherosclerosis. Cancer Res. 37:2232-35
15. Bond JA, Gwon AM, Yang HL, Benditt RP, Juchan MR. 1981. Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J. Toxicol. Environ. Health 7:327-35
16. Ou X, Ramos KS. 1992. Proliferative responses of quail aortic smooth muscle cells to benzo(a)pyrene: implications in PAH-induced atherogenesis. Toxicology 74:243-58
17. Ramos KS, Zhang Y, Sadhu DN, Chapkin RS. 1996. The induction of proliferative vascular smooth muscle cell phenotypes by benzo(a)pyrene is characterized by upregulation of inositol phospholipid metabolism and c-Ha-ras gene expression. Arch. Biochem. Biophys. 332:213-22